About us

Welcome to The Phage Therapy.

The Phage Therapy is an independent international scientific media platform dedicated exclusively to bacteriophages and phage therapy. Founded in 2025, the platform was created with the objective of providing reliable, accessible and comprehensive scientific information on one of the most promising alternatives to conventional antimicrobial therapies. Since its launch, it has progressively evolved into a global resource covering research, clinical applications, biotechnology, industry, regulation, education and innovation across the rapidly expanding field of phage science.

Our mission is to facilitate access to high-quality scientific information while promoting international collaboration between researchers, clinicians, healthcare professionals, biotechnology companies, students and everyone interested in bacteriophages. We believe that scientific knowledge should remain accessible to all and that independent scientific communication plays an essential role in accelerating research and encouraging collaboration across disciplines and countries.

The Phage Therapy publishes daily scientific news, feature articles, interviews, educational resources, historical archives, funding opportunities, career opportunities, conference coverage and in-depth analyses designed to serve both specialists and readers wishing to discover the field. Every publication is prepared with particular attention to scientific accuracy, transparency and the use of reliable sources. Our editorial policy is founded on independence, objectivity and evidence-based reporting, ensuring that editorial decisions remain entirely separate from any commercial partnership or sponsorship.

Alongside its editorial activities, The Phage Therapy develops free digital resources designed to improve access to information and strengthen international collaboration within the phage community. These include PhageAtLabs®, an interactive global directory of laboratories involved in bacteriophage research, PhageTrials Atlas®, a continuously updated atlas of bacteriophage therapy clinical trials, and PhageFundedProjects®, an interactive platform dedicated to European-funded bacteriophage research initiatives. Additional tools are currently under development with the ambition of creating one of the most comprehensive digital ecosystems dedicated to phage science.

The Phage Therapy remains an entirely independent project. Financial support generated through reader donations, sponsorships and carefully selected partnerships is entirely reinvested into maintaining and improving the platform, developing new educational resources and digital tools, expanding international scientific coverage and progressively supporting the contributors who participate in the project. Transparency, editorial independence and scientific integrity remain fundamental principles guiding every aspect of the platform's development.

As The Phage Therapy continues to grow, we are actively building an international editorial network bringing together experts from across the world. We are currently welcoming applications from researchers, clinicians, pharmacists, microbiologists, bioinformaticians, engineers, science communicators, PhD students and other professionals interested in contributing to the platform. We are particularly seeking members for our Editorial Board, Scientific Contributors, Regional Correspondents, Guest Authors and Scientific Reviewers. Whether your expertise lies in basic research, clinical practice, biotechnology, regulatory affairs, education or science communication, we would be delighted to collaborate with individuals who share our commitment to advancing bacteriophage science through accurate, accessible and independent scientific communication.

Beyond being an information platform, The Phage Therapy aims to become an international meeting point for the global bacteriophage community by encouraging collaboration between academia, healthcare institutions, industry and public stakeholders. Through the collective efforts of contributors from around the world, we hope to support the continued development of phage research, facilitate knowledge exchange and contribute to the growing recognition of bacteriophages as an essential component of future antimicrobial strategies.

If you are interested in contributing an article, sharing your research, becoming a Regional Correspondent, joining our Editorial Board, proposing a collaboration or supporting the continued development of the platform, we would be pleased to hear from you. Reader support plays a vital role in allowing us to maintain free access to our content and continue developing new scientific resources for the international community. You can support our work through our official Ko-fi page at https://ko-fi.com/thephagetherapy.

Thank you for visiting The Phage Therapy. We sincerely hope that the platform will become a valuable resource throughout your journey in the fascinating and rapidly evolving world of bacteriophages.

Comments

Most Consulted Articles

Bacteriophages Disarm Inflammation-Associated E. coli Without Erasing the Gut Microbiome in IBD

🌐 PhageAtLabs® — a global interactive mapping of academic laboratories in phage research.

History Part 12 : Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s)

The Phage Therapy in the spotlight !

Phagos Launches CAPHARD, a 900-Million-Parameter AI Model to Predict Phage–Bacteria Interactions